Eudaimonia Asset Management »

Protalix Biotherapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $331k 166k 2.00

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Kratos Defense & Security Solutions Common Stock (KTOS)
Sterling Infrastructure Common Stock (STRL)
Primoris Services Corp Common Stock (PRIM)
Rambus Common Stock (RMBS)
IonQ Common Stock (IONQ)
TTM Technologies Common Stock (TTMI)
Advanced Energy Industries Common Stock (AEIS)
Blackrock Funds - Equities ETF (SMIN)
Fabrinet Common Stock (FN)
nLight Common Stock (LASR)
SPX Technologies Common Stock (SPXC)
AeroVironment Common Stock (AVAV)
Bloom Energy Corp Common Stock (BE)
Talen Energy Corp Common Stock (TLN)

View all positions for Eudaimonia Asset Management

Top funds holding Protalix Biotherapeutics

BlackRock
Opaleye Management
Renaissance Technologies
Northern Trust
Geode Capital Management
Stratos Wealth Partners
State Street Corporation
Vanguard Group
Connor, Clark & Lunn Investment Management
UBS Group
Bridgeway Capital Management
Diametric Capital
Charles Schwab Investment Management
Commonwealth Equity Services
Evergreen Capital Management

View all funds holding Protalix Biotherapeutics